ICD-10-CM/PCS MS-DRG v41.1 Definitions Manual
Previous Page [Alt-p] Up a level [Alt-u] Next Page [Alt-n]
MDC 23 Factors influencing health status and other contacts with health services
Aftercare
Page 16 of 22

PRINCIPAL DIAGNOSIS (continued)

S0000XD S06384D S20372D S30872D S37001D S46092D S56406D S61327D S648X9D S70322D S83133D S91041D S99002K T2079XD T23552D T34811D T411X4D T458X1D T50A93D T63124D T81517D T85622D

T34811DFrostbite with tissue necrosis of right ankle, subsequent encounter
T34812DFrostbite with tissue necrosis of left ankle, subsequent encounter
T34819DFrostbite with tissue necrosis of unspecified ankle, subsequent encounter
T34821DFrostbite with tissue necrosis of right foot, subsequent encounter
T34822DFrostbite with tissue necrosis of left foot, subsequent encounter
T34829DFrostbite with tissue necrosis of unspecified foot, subsequent encounter
T34831DFrostbite with tissue necrosis of right toe(s), subsequent encounter
T34832DFrostbite with tissue necrosis of left toe(s), subsequent encounter
T34839DFrostbite with tissue necrosis of unspecified toe(s), subsequent encounter
T3490XDFrostbite with tissue necrosis of unspecified sites, subsequent encounter
T3499XDFrostbite with tissue necrosis of other sites, subsequent encounter
T360X1DPoisoning by penicillins, accidental (unintentional), subsequent encounter
T360X2DPoisoning by penicillins, intentional self-harm, subsequent encounter
T360X3DPoisoning by penicillins, assault, subsequent encounter
T360X4DPoisoning by penicillins, undetermined, subsequent encounter
T360X5DAdverse effect of penicillins, subsequent encounter
T360X6DUnderdosing of penicillins, subsequent encounter
T360X6SUnderdosing of penicillins, sequela
T361X1DPoisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), subsequent encounter
T361X2DPoisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, subsequent encounter
T361X3DPoisoning by cephalosporins and other beta-lactam antibiotics, assault, subsequent encounter
T361X4DPoisoning by cephalosporins and other beta-lactam antibiotics, undetermined, subsequent encounter
T361X5DAdverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
T361X6DUnderdosing of cephalosporins and other beta-lactam antibiotics, subsequent encounter
T361X6SUnderdosing of cephalosporins and other beta-lactam antibiotics, sequela
T362X1DPoisoning by chloramphenicol group, accidental (unintentional), subsequent encounter
T362X2DPoisoning by chloramphenicol group, intentional self-harm, subsequent encounter
T362X3DPoisoning by chloramphenicol group, assault, subsequent encounter
T362X4DPoisoning by chloramphenicol group, undetermined, subsequent encounter
T362X5DAdverse effect of chloramphenicol group, subsequent encounter
T362X6DUnderdosing of chloramphenicol group, subsequent encounter
T362X6SUnderdosing of chloramphenicol group, sequela
T363X1DPoisoning by macrolides, accidental (unintentional), subsequent encounter
T363X2DPoisoning by macrolides, intentional self-harm, subsequent encounter
T363X3DPoisoning by macrolides, assault, subsequent encounter
T363X4DPoisoning by macrolides, undetermined, subsequent encounter
T363X5DAdverse effect of macrolides, subsequent encounter
T363X6DUnderdosing of macrolides, subsequent encounter
T363X6SUnderdosing of macrolides, sequela
T364X1DPoisoning by tetracyclines, accidental (unintentional), subsequent encounter
T364X2DPoisoning by tetracyclines, intentional self-harm, subsequent encounter
T364X3DPoisoning by tetracyclines, assault, subsequent encounter
T364X4DPoisoning by tetracyclines, undetermined, subsequent encounter
T364X5DAdverse effect of tetracyclines, subsequent encounter
T364X6DUnderdosing of tetracyclines, subsequent encounter
T364X6SUnderdosing of tetracyclines, sequela
T365X1DPoisoning by aminoglycosides, accidental (unintentional), subsequent encounter
T365X2DPoisoning by aminoglycosides, intentional self-harm, subsequent encounter
T365X3DPoisoning by aminoglycosides, assault, subsequent encounter
T365X4DPoisoning by aminoglycosides, undetermined, subsequent encounter
T365X5DAdverse effect of aminoglycosides, subsequent encounter
T365X6DUnderdosing of aminoglycosides, subsequent encounter
T365X6SUnderdosing of aminoglycosides, sequela
T366X1DPoisoning by rifampicins, accidental (unintentional), subsequent encounter
T366X2DPoisoning by rifampicins, intentional self-harm, subsequent encounter
T366X3DPoisoning by rifampicins, assault, subsequent encounter
T366X4DPoisoning by rifampicins, undetermined, subsequent encounter
T366X5DAdverse effect of rifampicins, subsequent encounter
T366X6DUnderdosing of rifampicins, subsequent encounter
T366X6SUnderdosing of rifampicins, sequela
T367X1DPoisoning by antifungal antibiotics, systemically used, accidental (unintentional), subsequent encounter
T367X2DPoisoning by antifungal antibiotics, systemically used, intentional self-harm, subsequent encounter
T367X3DPoisoning by antifungal antibiotics, systemically used, assault, subsequent encounter
T367X4DPoisoning by antifungal antibiotics, systemically used, undetermined, subsequent encounter
T367X5DAdverse effect of antifungal antibiotics, systemically used, subsequent encounter
T367X6DUnderdosing of antifungal antibiotics, systemically used, subsequent encounter
T367X6SUnderdosing of antifungal antibiotics, systemically used, sequela
T368X1DPoisoning by other systemic antibiotics, accidental (unintentional), subsequent encounter
T368X2DPoisoning by other systemic antibiotics, intentional self-harm, subsequent encounter
T368X3DPoisoning by other systemic antibiotics, assault, subsequent encounter
T368X4DPoisoning by other systemic antibiotics, undetermined, subsequent encounter
T368X5DAdverse effect of other systemic antibiotics, subsequent encounter
T368X6DUnderdosing of other systemic antibiotics, subsequent encounter
T368X6SUnderdosing of other systemic antibiotics, sequela
T3691XDPoisoning by unspecified systemic antibiotic, accidental (unintentional), subsequent encounter
T3692XDPoisoning by unspecified systemic antibiotic, intentional self-harm, subsequent encounter
T3693XDPoisoning by unspecified systemic antibiotic, assault, subsequent encounter
T3694XDPoisoning by unspecified systemic antibiotic, undetermined, subsequent encounter
T3695XDAdverse effect of unspecified systemic antibiotic, subsequent encounter
T3696XDUnderdosing of unspecified systemic antibiotic, subsequent encounter
T3696XSUnderdosing of unspecified systemic antibiotic, sequela
T370X1DPoisoning by sulfonamides, accidental (unintentional), subsequent encounter
T370X2DPoisoning by sulfonamides, intentional self-harm, subsequent encounter
T370X3DPoisoning by sulfonamides, assault, subsequent encounter
T370X4DPoisoning by sulfonamides, undetermined, subsequent encounter
T370X5DAdverse effect of sulfonamides, subsequent encounter
T370X6DUnderdosing of sulfonamides, subsequent encounter
T370X6SUnderdosing of sulfonamides, sequela
T371X1DPoisoning by antimycobacterial drugs, accidental (unintentional), subsequent encounter
T371X2DPoisoning by antimycobacterial drugs, intentional self-harm, subsequent encounter
T371X3DPoisoning by antimycobacterial drugs, assault, subsequent encounter
T371X4DPoisoning by antimycobacterial drugs, undetermined, subsequent encounter
T371X5DAdverse effect of antimycobacterial drugs, subsequent encounter
T371X6DUnderdosing of antimycobacterial drugs, subsequent encounter
T371X6SUnderdosing of antimycobacterial drugs, sequela
T372X1DPoisoning by antimalarials and drugs acting on other blood protozoa, accidental (unintentional), subsequent encounter
T372X2DPoisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm, subsequent encounter
T372X3DPoisoning by antimalarials and drugs acting on other blood protozoa, assault, subsequent encounter
T372X4DPoisoning by antimalarials and drugs acting on other blood protozoa, undetermined, subsequent encounter
T372X5DAdverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
T372X6DUnderdosing of antimalarials and drugs acting on other blood protozoa, subsequent encounter
T372X6SUnderdosing of antimalarials and drugs acting on other blood protozoa, sequela
T373X1DPoisoning by other antiprotozoal drugs, accidental (unintentional), subsequent encounter
T373X2DPoisoning by other antiprotozoal drugs, intentional self-harm, subsequent encounter
T373X3DPoisoning by other antiprotozoal drugs, assault, subsequent encounter
T373X4DPoisoning by other antiprotozoal drugs, undetermined, subsequent encounter
T373X5DAdverse effect of other antiprotozoal drugs, subsequent encounter
T373X6DUnderdosing of other antiprotozoal drugs, subsequent encounter
T373X6SUnderdosing of other antiprotozoal drugs, sequela
T374X1DPoisoning by anthelminthics, accidental (unintentional), subsequent encounter
T374X2DPoisoning by anthelminthics, intentional self-harm, subsequent encounter
T374X3DPoisoning by anthelminthics, assault, subsequent encounter
T374X4DPoisoning by anthelminthics, undetermined, subsequent encounter
T374X5DAdverse effect of anthelminthics, subsequent encounter
T374X6DUnderdosing of anthelminthics, subsequent encounter
T374X6SUnderdosing of anthelminthics, sequela
T375X1DPoisoning by antiviral drugs, accidental (unintentional), subsequent encounter
T375X2DPoisoning by antiviral drugs, intentional self-harm, subsequent encounter
T375X3DPoisoning by antiviral drugs, assault, subsequent encounter
T375X4DPoisoning by antiviral drugs, undetermined, subsequent encounter
T375X5DAdverse effect of antiviral drugs, subsequent encounter
T375X6DUnderdosing of antiviral drugs, subsequent encounter
T375X6SUnderdosing of antiviral drugs, sequela
T378X1DPoisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), subsequent encounter
T378X2DPoisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm, subsequent encounter
T378X3DPoisoning by other specified systemic anti-infectives and antiparasitics, assault, subsequent encounter
T378X4DPoisoning by other specified systemic anti-infectives and antiparasitics, undetermined, subsequent encounter
T378X5DAdverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
T378X6DUnderdosing of other specified systemic anti-infectives and antiparasitics, subsequent encounter
T378X6SUnderdosing of other specified systemic anti-infectives and antiparasitics, sequela
T3791XDPoisoning by unspecified systemic anti-infective and antiparasitics, accidental (unintentional), subsequent encounter
T3792XDPoisoning by unspecified systemic anti-infective and antiparasitics, intentional self-harm, subsequent encounter
T3793XDPoisoning by unspecified systemic anti-infective and antiparasitics, assault, subsequent encounter
T3794XDPoisoning by unspecified systemic anti-infective and antiparasitics, undetermined, subsequent encounter
T3795XDAdverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
T3796XDUnderdosing of unspecified systemic anti-infectives and antiparasitics, subsequent encounter
T3796XSUnderdosing of unspecified systemic anti-infectives and antiparasitics, sequela
T380X1DPoisoning by glucocorticoids and synthetic analogues, accidental (unintentional), subsequent encounter
T380X2DPoisoning by glucocorticoids and synthetic analogues, intentional self-harm, subsequent encounter
T380X3DPoisoning by glucocorticoids and synthetic analogues, assault, subsequent encounter
T380X4DPoisoning by glucocorticoids and synthetic analogues, undetermined, subsequent encounter
T380X5DAdverse effect of glucocorticoids and synthetic analogues, subsequent encounter
T380X6DUnderdosing of glucocorticoids and synthetic analogues, subsequent encounter
T380X6SUnderdosing of glucocorticoids and synthetic analogues, sequela
T381X1DPoisoning by thyroid hormones and substitutes, accidental (unintentional), subsequent encounter
T381X2DPoisoning by thyroid hormones and substitutes, intentional self-harm, subsequent encounter
T381X3DPoisoning by thyroid hormones and substitutes, assault, subsequent encounter
T381X4DPoisoning by thyroid hormones and substitutes, undetermined, subsequent encounter
T381X5DAdverse effect of thyroid hormones and substitutes, subsequent encounter
T381X6DUnderdosing of thyroid hormones and substitutes, subsequent encounter
T381X6SUnderdosing of thyroid hormones and substitutes, sequela
T382X1DPoisoning by antithyroid drugs, accidental (unintentional), subsequent encounter
T382X2DPoisoning by antithyroid drugs, intentional self-harm, subsequent encounter
T382X3DPoisoning by antithyroid drugs, assault, subsequent encounter
T382X4DPoisoning by antithyroid drugs, undetermined, subsequent encounter
T382X5DAdverse effect of antithyroid drugs, subsequent encounter
T382X6DUnderdosing of antithyroid drugs, subsequent encounter
T382X6SUnderdosing of antithyroid drugs, sequela
T383X1DPoisoning by insulin and oral hypoglycemic [antidiabetic] drugs, accidental (unintentional), subsequent encounter
T383X2DPoisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm, subsequent encounter
T383X3DPoisoning by insulin and oral hypoglycemic [antidiabetic] drugs, assault, subsequent encounter
T383X4DPoisoning by insulin and oral hypoglycemic [antidiabetic] drugs, undetermined, subsequent encounter
T383X5DAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
T383X6DUnderdosing of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
T383X6SUnderdosing of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
T384X1DPoisoning by oral contraceptives, accidental (unintentional), subsequent encounter
T384X2DPoisoning by oral contraceptives, intentional self-harm, subsequent encounter
T384X3DPoisoning by oral contraceptives, assault, subsequent encounter
T384X4DPoisoning by oral contraceptives, undetermined, subsequent encounter
T384X5DAdverse effect of oral contraceptives, subsequent encounter
T384X6DUnderdosing of oral contraceptives, subsequent encounter
T384X6SUnderdosing of oral contraceptives, sequela
T385X1DPoisoning by other estrogens and progestogens, accidental (unintentional), subsequent encounter
T385X2DPoisoning by other estrogens and progestogens, intentional self-harm, subsequent encounter
T385X3DPoisoning by other estrogens and progestogens, assault, subsequent encounter
T385X4DPoisoning by other estrogens and progestogens, undetermined, subsequent encounter
T385X5DAdverse effect of other estrogens and progestogens, subsequent encounter
T385X6DUnderdosing of other estrogens and progestogens, subsequent encounter
T385X6SUnderdosing of other estrogens and progestogens, sequela
T386X1DPoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), subsequent encounter
T386X2DPoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, subsequent encounter
T386X3DPoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, assault, subsequent encounter
T386X4DPoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, undetermined, subsequent encounter
T386X5DAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
T386X6DUnderdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
T386X6SUnderdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
T387X1DPoisoning by androgens and anabolic congeners, accidental (unintentional), subsequent encounter
T387X2DPoisoning by androgens and anabolic congeners, intentional self-harm, subsequent encounter
T387X3DPoisoning by androgens and anabolic congeners, assault, subsequent encounter
T387X4DPoisoning by androgens and anabolic congeners, undetermined, subsequent encounter
T387X5DAdverse effect of androgens and anabolic congeners, subsequent encounter
T387X6DUnderdosing of androgens and anabolic congeners, subsequent encounter
T387X6SUnderdosing of androgens and anabolic congeners, sequela
T38801DPoisoning by unspecified hormones and synthetic substitutes, accidental (unintentional), subsequent encounter
T38802DPoisoning by unspecified hormones and synthetic substitutes, intentional self-harm, subsequent encounter
T38803DPoisoning by unspecified hormones and synthetic substitutes, assault, subsequent encounter
T38804DPoisoning by unspecified hormones and synthetic substitutes, undetermined, subsequent encounter
T38805DAdverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
T38806DUnderdosing of unspecified hormones and synthetic substitutes, subsequent encounter
T38806SUnderdosing of unspecified hormones and synthetic substitutes, sequela
T38811DPoisoning by anterior pituitary [adenohypophyseal] hormones, accidental (unintentional), subsequent encounter
T38812DPoisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm, subsequent encounter
T38813DPoisoning by anterior pituitary [adenohypophyseal] hormones, assault, subsequent encounter
T38814DPoisoning by anterior pituitary [adenohypophyseal] hormones, undetermined, subsequent encounter
T38815DAdverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
T38816DUnderdosing of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
T38816SUnderdosing of anterior pituitary [adenohypophyseal] hormones, sequela
T38891DPoisoning by other hormones and synthetic substitutes, accidental (unintentional), subsequent encounter
T38892DPoisoning by other hormones and synthetic substitutes, intentional self-harm, subsequent encounter
T38893DPoisoning by other hormones and synthetic substitutes, assault, subsequent encounter
T38894DPoisoning by other hormones and synthetic substitutes, undetermined, subsequent encounter
T38895DAdverse effect of other hormones and synthetic substitutes, subsequent encounter
T38896DUnderdosing of other hormones and synthetic substitutes, subsequent encounter
T38896SUnderdosing of other hormones and synthetic substitutes, sequela
T38901DPoisoning by unspecified hormone antagonists, accidental (unintentional), subsequent encounter
T38902DPoisoning by unspecified hormone antagonists, intentional self-harm, subsequent encounter
T38903DPoisoning by unspecified hormone antagonists, assault, subsequent encounter
T38904DPoisoning by unspecified hormone antagonists, undetermined, subsequent encounter
T38905DAdverse effect of unspecified hormone antagonists, subsequent encounter
T38906DUnderdosing of unspecified hormone antagonists, subsequent encounter
T38906SUnderdosing of unspecified hormone antagonists, sequela
T38991DPoisoning by other hormone antagonists, accidental (unintentional), subsequent encounter
T38992DPoisoning by other hormone antagonists, intentional self-harm, subsequent encounter
T38993DPoisoning by other hormone antagonists, assault, subsequent encounter
T38994DPoisoning by other hormone antagonists, undetermined, subsequent encounter
T38995DAdverse effect of other hormone antagonists, subsequent encounter
T38996DUnderdosing of other hormone antagonists, subsequent encounter
T38996SUnderdosing of other hormone antagonists, sequela
T39011DPoisoning by aspirin, accidental (unintentional), subsequent encounter
T39012DPoisoning by aspirin, intentional self-harm, subsequent encounter
T39013DPoisoning by aspirin, assault, subsequent encounter
T39014DPoisoning by aspirin, undetermined, subsequent encounter
T39015DAdverse effect of aspirin, subsequent encounter
T39016DUnderdosing of aspirin, subsequent encounter
T39016SUnderdosing of aspirin, sequela
T39091DPoisoning by salicylates, accidental (unintentional), subsequent encounter
T39092DPoisoning by salicylates, intentional self-harm, subsequent encounter
T39093DPoisoning by salicylates, assault, subsequent encounter
T39094DPoisoning by salicylates, undetermined, subsequent encounter
T39095DAdverse effect of salicylates, subsequent encounter
T39096DUnderdosing of salicylates, subsequent encounter
T39096SUnderdosing of salicylates, sequela
T391X1DPoisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter
T391X2DPoisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter
T391X3DPoisoning by 4-Aminophenol derivatives, assault, subsequent encounter
T391X4DPoisoning by 4-Aminophenol derivatives, undetermined, subsequent encounter
T391X5DAdverse effect of 4-Aminophenol derivatives, subsequent encounter
T391X6DUnderdosing of 4-Aminophenol derivatives, subsequent encounter
T391X6SUnderdosing of 4-Aminophenol derivatives, sequela
T392X1DPoisoning by pyrazolone derivatives, accidental (unintentional), subsequent encounter
T392X2DPoisoning by pyrazolone derivatives, intentional self-harm, subsequent encounter
T392X3DPoisoning by pyrazolone derivatives, assault, subsequent encounter
T392X4DPoisoning by pyrazolone derivatives, undetermined, subsequent encounter
T392X5DAdverse effect of pyrazolone derivatives, subsequent encounter
T392X6DUnderdosing of pyrazolone derivatives, subsequent encounter
T392X6SUnderdosing of pyrazolone derivatives, sequela
T39311DPoisoning by propionic acid derivatives, accidental (unintentional), subsequent encounter
T39312DPoisoning by propionic acid derivatives, intentional self-harm, subsequent encounter
T39313DPoisoning by propionic acid derivatives, assault, subsequent encounter
T39314DPoisoning by propionic acid derivatives, undetermined, subsequent encounter
T39315DAdverse effect of propionic acid derivatives, subsequent encounter
T39316DUnderdosing of propionic acid derivatives, subsequent encounter
T39316SUnderdosing of propionic acid derivatives, sequela
T39391DPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), subsequent encounter
T39392DPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, subsequent encounter
T39393DPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, subsequent encounter
T39394DPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, subsequent encounter
T39395DAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T39396DUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T39396SUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
T394X1DPoisoning by antirheumatics, not elsewhere classified, accidental (unintentional), subsequent encounter
T394X2DPoisoning by antirheumatics, not elsewhere classified, intentional self-harm, subsequent encounter
T394X3DPoisoning by antirheumatics, not elsewhere classified, assault, subsequent encounter
T394X4DPoisoning by antirheumatics, not elsewhere classified, undetermined, subsequent encounter
T394X5DAdverse effect of antirheumatics, not elsewhere classified, subsequent encounter
T394X6DUnderdosing of antirheumatics, not elsewhere classified, subsequent encounter
T394X6SUnderdosing of antirheumatics, not elsewhere classified, sequela
T398X1DPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), subsequent encounter
T398X2DPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, subsequent encounter
T398X3DPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, subsequent encounter
T398X4DPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, subsequent encounter
T398X5DAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
T398X6DUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
T398X6SUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
T3991XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), subsequent encounter
T3992XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, subsequent encounter
T3993XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, subsequent encounter
T3994XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, subsequent encounter
T3995XDAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
T3996XDUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
T3996XSUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
T400X1DPoisoning by opium, accidental (unintentional), subsequent encounter
T400X2DPoisoning by opium, intentional self-harm, subsequent encounter
T400X3DPoisoning by opium, assault, subsequent encounter
T400X4DPoisoning by opium, undetermined, subsequent encounter
T400X5DAdverse effect of opium, subsequent encounter
T400X6DUnderdosing of opium, subsequent encounter
T400X6SUnderdosing of opium, sequela
T401X1DPoisoning by heroin, accidental (unintentional), subsequent encounter
T401X2DPoisoning by heroin, intentional self-harm, subsequent encounter
T401X3DPoisoning by heroin, assault, subsequent encounter
T401X4DPoisoning by heroin, undetermined, subsequent encounter
T402X1DPoisoning by other opioids, accidental (unintentional), subsequent encounter
T402X2DPoisoning by other opioids, intentional self-harm, subsequent encounter
T402X3DPoisoning by other opioids, assault, subsequent encounter
T402X4DPoisoning by other opioids, undetermined, subsequent encounter
T402X5DAdverse effect of other opioids, subsequent encounter
T402X6DUnderdosing of other opioids, subsequent encounter
T402X6SUnderdosing of other opioids, sequela
T403X1DPoisoning by methadone, accidental (unintentional), subsequent encounter
T403X2DPoisoning by methadone, intentional self-harm, subsequent encounter
T403X3DPoisoning by methadone, assault, subsequent encounter
T403X4DPoisoning by methadone, undetermined, subsequent encounter
T403X5DAdverse effect of methadone, subsequent encounter
T403X6DUnderdosing of methadone, subsequent encounter
T403X6SUnderdosing of methadone, sequela
T40411DPoisoning by fentanyl or fentanyl analogs, accidental (unintentional), subsequent encounter
T40412DPoisoning by fentanyl or fentanyl analogs, intentional self-harm, subsequent encounter
T40413DPoisoning by fentanyl or fentanyl analogs, assault, subsequent encounter
T40414DPoisoning by fentanyl or fentanyl analogs, undetermined, subsequent encounter
T40415DAdverse effect of fentanyl or fentanyl analogs, subsequent encounter
T40416DUnderdosing of fentanyl or fentanyl analogs, subsequent encounter
T40416SUnderdosing of fentanyl or fentanyl analogs, sequela
T40421DPoisoning by tramadol, accidental (unintentional), subsequent encounter
T40422DPoisoning by tramadol, intentional self-harm, subsequent encounter
T40423DPoisoning by tramadol, assault, subsequent encounter
T40424DPoisoning by tramadol, undetermined, subsequent encounter
T40425DAdverse effect of tramadol, subsequent encounter
T40426DUnderdosing of tramadol, subsequent encounter
T40426SUnderdosing of tramadol, sequela
T40491DPoisoning by other synthetic narcotics, accidental (unintentional), subsequent encounter
T40492DPoisoning by other synthetic narcotics, intentional self-harm, subsequent encounter
T40493DPoisoning by other synthetic narcotics, assault, subsequent encounter
T40494DPoisoning by other synthetic narcotics, undetermined, subsequent encounter
T40495DAdverse effect of other synthetic narcotics, subsequent encounter
T40496DUnderdosing of other synthetic narcotics, subsequent encounter
T40496SUnderdosing of other synthetic narcotics, sequela
T405X1DPoisoning by cocaine, accidental (unintentional), subsequent encounter
T405X2DPoisoning by cocaine, intentional self-harm, subsequent encounter
T405X3DPoisoning by cocaine, assault, subsequent encounter
T405X4DPoisoning by cocaine, undetermined, subsequent encounter
T405X5DAdverse effect of cocaine, subsequent encounter
T405X6DUnderdosing of cocaine, subsequent encounter
T405X6SUnderdosing of cocaine, sequela
T40601DPoisoning by unspecified narcotics, accidental (unintentional), subsequent encounter
T40602DPoisoning by unspecified narcotics, intentional self-harm, subsequent encounter
T40603DPoisoning by unspecified narcotics, assault, subsequent encounter
T40604DPoisoning by unspecified narcotics, undetermined, subsequent encounter
T40605DAdverse effect of unspecified narcotics, subsequent encounter
T40606DUnderdosing of unspecified narcotics, subsequent encounter
T40606SUnderdosing of unspecified narcotics, sequela
T40691DPoisoning by other narcotics, accidental (unintentional), subsequent encounter
T40692DPoisoning by other narcotics, intentional self-harm, subsequent encounter
T40693DPoisoning by other narcotics, assault, subsequent encounter
T40694DPoisoning by other narcotics, undetermined, subsequent encounter
T40695DAdverse effect of other narcotics, subsequent encounter
T40696DUnderdosing of other narcotics, subsequent encounter
T40696SUnderdosing of other narcotics, sequela
T40711DPoisoning by cannabis, accidental (unintentional), subsequent encounter
T40712DPoisoning by cannabis, intentional self-harm, subsequent encounter
T40713DPoisoning by cannabis, assault, subsequent encounter
T40714DPoisoning by cannabis, undetermined, subsequent encounter
T40715DAdverse effect of cannabis, subsequent encounter
T40716DUnderdosing of cannabis, subsequent encounter
T40716SUnderdosing of cannabis, sequela
T40721DPoisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
T40722DPoisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
T40723DPoisoning by synthetic cannabinoids, assault, subsequent encounter
T40724DPoisoning by synthetic cannabinoids, undetermined, subsequent encounter
T40725DAdverse effect of synthetic cannabinoids, subsequent encounter
T40726DUnderdosing of synthetic cannabinoids, subsequent encounter
T40726SUnderdosing of synthetic cannabinoids, sequela
T408X1DPoisoning by lysergide [LSD], accidental (unintentional), subsequent encounter
T408X2DPoisoning by lysergide [LSD], intentional self-harm, subsequent encounter
T408X3DPoisoning by lysergide [LSD], assault, subsequent encounter
T408X4DPoisoning by lysergide [LSD], undetermined, subsequent encounter
T40901DPoisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter
T40902DPoisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter
T40903DPoisoning by unspecified psychodysleptics [hallucinogens], assault, subsequent encounter
T40904DPoisoning by unspecified psychodysleptics [hallucinogens], undetermined, subsequent encounter
T40905DAdverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
T40906DUnderdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter
T40906SUnderdosing of unspecified psychodysleptics [hallucinogens], sequela
T40991DPoisoning by other psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter
T40992DPoisoning by other psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter
T40993DPoisoning by other psychodysleptics [hallucinogens], assault, subsequent encounter
T40994DPoisoning by other psychodysleptics [hallucinogens], undetermined, subsequent encounter
T40995DAdverse effect of other psychodysleptics [hallucinogens], subsequent encounter
T40996DUnderdosing of other psychodysleptics [hallucinogens], subsequent encounter
T40996SUnderdosing of other psychodysleptics [hallucinogens], sequela
T410X1DPoisoning by inhaled anesthetics, accidental (unintentional), subsequent encounter
T410X2DPoisoning by inhaled anesthetics, intentional self-harm, subsequent encounter
T410X3DPoisoning by inhaled anesthetics, assault, subsequent encounter
T410X4DPoisoning by inhaled anesthetics, undetermined, subsequent encounter
T410X5DAdverse effect of inhaled anesthetics, subsequent encounter
T410X6DUnderdosing of inhaled anesthetics, subsequent encounter
T410X6SUnderdosing of inhaled anesthetics, sequela
T411X1DPoisoning by intravenous anesthetics, accidental (unintentional), subsequent encounter
T411X2DPoisoning by intravenous anesthetics, intentional self-harm, subsequent encounter
T411X3DPoisoning by intravenous anesthetics, assault, subsequent encounter



Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244
08 Mar 2024 10:29:37
CMS, code-revision=359, description-revision=1383